University of Arizona

City:

Amount: $100000

Award Date: 2025

Duration: 18 months

Program Area: Bioscience

Translational Seed Grant: For colorectal cancer, the proposed pharmaceutical aims to stop growth of tumors and boost the immune system’s ability to fight cancer cells in combination with using immuno-oncology medication botensilimab and balstilimab. This team is developing a new drug (CC895) that inhibits a pathway that is very active in colorectal cancer.